FEI Endurance Strategic Planning Group Holds First Meeting
Edited Press Release
September 12, 2013
The group aims to help participants adhere to Clean Sport’ standards and code of conduct for horse welfare.
The group aims to help participants adhere to Clean Sport’ standards and code of conduct for horse welfare.
Among the measures is early out-of-competition blood testing for banned substances.
KHRC Medical Director Mary Scollay, DVM, gave an introduction to the Mid-Atlantic Uniform Medication Program.
Panelists said public perception is based on biased representation by press and industry organizations.
The Jockey Club recommended that all U.S. racing jurisdictions pledge to adopt a uniform medication program.
The Jockey Club will provide funds to some racing jurisdictions to step up out-of-competition drug testing.
The BHA concluded its investigation into “Sungate,” a veterinary product which contains an anabolic steroid.
RCI voted to approve model rules that create a points system and enhanced penalties for drug violations.
An official explains why confidentiality is used when setting medication thresholds and withdrawal times.
Regulatory administration of race-day anti-bleeding medication has provided a clearer picture of drug testing.
The Kentucky Horse Racing Commission approved a “rapid response” protocol to examine emerging illegal drugs.
The model rule represents a plan to provide appropriate penalties for violations of medication regulations.
The regulations are a “living document” that likely will be adjusted based on industry needs, one group says.
Some veterinarians expressed concerns over the proposed clenbuterol withdrawal time and testing levels.
The drugs, only available through compounding pharmacies, will be high-level violations if used in racing.
Ohio horsemen will pay more to offset the cost of equine drug testing under a resolution adopted June 27.
Stay on top of the most recent Horse Health news with
